KLRA
Kailera Therapeutics, Inc.
10.40$
-5.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Kailera Therapeutics, Inc. (KLRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -78 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| -18 | -26 | -68 | -78 | |
| 0.1 | 0.1 | 0.1 | 0.1 | |
| 1.5 | 1.6 | 3.9 | 8.3 | |
| -1.0 | 1.3 | 7.5 | 27 | |
| 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | 23 | -571 | |
| 0.0 | 100 | -3.0 | 667 | |
| -73 | -0.4 | -48 | 18 | |
| -18 | -26 | -68 | -78 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.